BiotechTube
Home/Kling Biotherapeutics/Stefano Gulla
SG

Stefano Gulla

Chief Scientific Officer (CSO)

Kling Biotherapeutics

Therapeutic Areas

OncologyInfectious Diseases

Kling Biotherapeutics Pipeline

DrugIndicationPhase
KBA1412Oncology (likely solid tumors)Phase 1

Leadership Team at Kling Biotherapeutics

TW
Tim Wright
Chairman of the Board
View full Kling Biotherapeutics profile